The Global Anastomosis Devices Market Set for Promising Growth by 2032, Driven by Minimally Invasive Surgical Advancements and Increasing Surgical Volume | DelveInsight

The anastomosis devices market is poised for steady growth through 2032, driven by rising demand for minimally invasive procedures, increasing prevalence of gastrointestinal, cardiovascular, and bariatric surgeries, and continuous advancements in surgical technologies. These devices play a critical role in ensuring secure, efficient, and faster connections between anatomical structures, thereby enhancing patient outcomes and reducing post-operative complications.

Technological innovations, such as automated and sutureless anastomosis devices, bioabsorbable materials, and precision-guided stapling systems, are transforming the surgical landscape, supporting faster healing and reducing procedural times. The growing adoption of robotic and laparoscopic-assisted surgeries further boosts the need for efficient and safe anastomosis solutions.

DelveInsight's Anastomosis Devices Market Insights report offers a detailed market outlook, including current and forecast analysis, key market drivers and challenges, emerging trends, and the competitive landscape. The report also profiles leading companies in the anastomosis device market, highlighting recent developments, regulatory approvals, and strategic initiatives shaping the future of surgical care.

Explore the latest trends and growth drivers in the anastomosis devices Market-download your sample report now https://www.delveinsight.com/report-store/anastomosis-device-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Key Takeaways from the Anastomosis Device Market Report
• The global anastomosis devices market is projected to experience significant growth, expanding steadily and reaching a substantial value by 2032.
• As per DelveInsight estimates, North America is anticipated to dominate the global anastomosis devices market during the forecast period.
• Notable anastomosis devices companies such as B. Braun Melsungen AG, Intuitive Surgical, BAXTER, CryoLife, Johnson & Johnson Services, Medtronic, Sinolinks Medical Innovation, microcuremed, BIOWIN PHARMACEUTICAL, Waston Medical Corporation, W. L. Gore & Associates, Hangzhou Demo Medical Technology, Dolphin Sutures, gpcmedical, Golden Stapler Surgical, JIANGSU JOYMED TECH, Changzhou Haiers Medical Devices Co., Ltd, Shanghai MedEco Industry, ChangZhou WeiPu Medical Devices, and several others are currently operating in the anastomosis devices market.
• In May 2025, Minneapolis-based medical device company Phraxis Inc. achieved a significant milestone with FDA approval of its EndoForceTM Connector for Endovascular Venous Anastomosis (EndoForceTM), marking a key advancement in dialysis access technology.
• In March 2025, GT Metabolic Solutions, a company specializing in magnetic surgery, earned U.S. Food and Drug Administration (FDA) clearance for a larger, 50 mm MagDI magnet to complement the system's current 40 mm magnet. The expansion allows surgeons to accommodate a wider range of patients in magnet-assisted surgery for duodenal-ilial anastomosis. The MagDI system is currently the only FDA-cleared, commercially available product for magnetic compression anastomosis.
• In September 2024, GT MetabolicTM Solutions, Inc., a company focused on transforming bariatric, metabolic, and digestive surgery, announced that its first-generation MagDITM System for side-to-side duodeno-ileal anastomosis received De Novo marketing authorization from the U.S. Food and Drug Administration (FDA).

To read more about the latest highlights related to the anastomosis devices market, get a snapshot of the key highlights entailed in the global anastomosis devices market report here https://www.delveinsight.com/report-store/anastomosis-device-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Anastomosis Device Overview
Anastomosis devices are specialized surgical tools designed to connect two tubular structures such as blood vessels or segments of the intestine, typically after a resection or during bypass procedures. These devices are critical in various surgical interventions, including gastrointestinal, cardiovascular, and transplant surgeries, where secure and efficient reconnection of tissues is vital for patient recovery.

The global demand for anastomosis devices is rising due to increasing surgical volumes driven by a surge in chronic conditions like colorectal cancer, obesity, and cardiovascular disorders. Compared to traditional suturing, these devices offer advantages such as reduced operative time, minimized blood loss, lower risk of leakage or infection, and improved patient outcomes. Technological advancements in stapling, magnetic compression, and bioresorbable materials are further enhancing device performance and expanding their application across open and minimally invasive surgeries.

As healthcare systems increasingly adopt minimally invasive techniques and enhanced recovery protocols, anastomosis devices continue to play a pivotal role in modern surgical care, making them an essential segment within the broader surgical device market.

Anastomosis Device Market Insights
North America is expected to hold a dominant share in the anastomosis devices market during the forecast period (2025-2032), driven by rising colorectal cancer cases, strong presence of key market players, and continuous product innovation. According to the Global Cancer Observatory 2024, the region reported 183,911 colorectal cancer cases in 2022, with the U.S. accounting for nearly 87% of them. This high disease burden is boosting demand for advanced anastomosis devices, which are critical in bowel reconnection surgeries.

Additionally, FDA approvals-such as the October 2024 clearance of GT Metabolic's MagDITM System-underscore regulatory momentum supporting market growth. A well-established healthcare infrastructure, favorable reimbursement policies, and the wide distribution networks of major players like Johnson & Johnson, B. Braun, and Medtronic further contribute to the expansion of the anastomosis devices market in North America.

To know more about why North America is leading the market growth in the anastomosis devices market, get a snapshot of the anastomosis device market outlook here https://www.delveinsight.com/report-store/anastomosis-device-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Anastomosis Device Market Dynamics
According to the Global Cancer Observatory 2024, approximately 1,926,425 colorectal cancer cases were reported globally in 2022. Asia accounted for nearly half of these cases, with 966,399 reported, while Europe reported 538,262 cases. This high global burden of colorectal cancer significantly drives the demand for surgical interventions where anastomosis devices play a vital role in reconnecting bowel segments post-resection. These devices offer greater surgical precision, reduce complication risks, and support better patient outcomes, making them essential in colorectal cancer management and boosting their market adoption.

In addition, coronary artery disease (CAD) continues to be a major global health issue, with the British Heart Foundation's 2024 Global Heart & Circulatory Diseases Factsheet reporting around 200 million individuals living with CAD worldwide. Anastomosis devices are increasingly used in procedures like coronary artery bypass grafting (CABG), where they enhance surgical efficiency and reduce postoperative complications, thus becoming more integral to CAD treatment strategies.

Market growth is also supported by innovation and regulatory approvals. For instance, in January 2023, Lydus Medical's Vesseal microvascular anastomosis suture deployment system received 510(k) clearance from the US FDA, underscoring the advancement of device technology in this space.

However, market expansion may face challenges such as complications associated with anastomosis procedures and the rising preference for minimally invasive or non-invasive treatment approaches, which could limit the adoption of conventional anastomosis devices during the forecast period from 2025 to 2032.

Get a sneak peek at the Anastomosis Device market dynamics @ https://www.delveinsight.com/report-store/anastomosis-device-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Coverage: Global
Study Period: 2022 to 2032
Anastomosis Device Market CAGR: ~5.3%
Key Anastomosis Device Companies: B. Braun Melsungen AG, Intuitive Surgical, BAXTER, CryoLife, Johnson & Johnson Services, Medtronic, Sinolinks Medical Innovation, microcuremed, BIOWIN PHARMACEUTICAL, Waston Medical Corporation, W. L. Gore & Associates, Hangzhou Demo Medical Technology, Dolphin Sutures, gpcmedical, Golden Stapler Surgical, JIANGSU JOYMED TECH, Changzhou Haiers Medical Devices Co., Ltd, Shanghai MedEco Industry, ChangZhou WeiPu Medical Devices, and others.

Anastomosis Device Market Segmentation
Market Segmentation By Product: Surgical Staplers, Surgical Sutures, Surgical Sealants, and Surgical Adhesives.
Market Segmentation By Usability: Disposable and Reusable.
Market Segmentation By Application: Cardiovascular Surgery, Gastrointestinal Surgery, and others.
Market Segmentation By End User: Hospitals & Clinics, Ambulatory Surgical Centers, and others.
Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World.

Which MedTech key players in the Anastomosis Device market are set to emerge as the trendsetter, explore @ https://www.delveinsight.com/report-store/anastomosis-device-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Table of Contents
1. Anastomosis Device Market Report Introduction
2. Anastomosis Device Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Anastomosis Device Market Key Factors Analysis
6. Anastomosis Device Market Porter's Five Forces Analysis
7. Anastomosis Device Market Layout
8. Anastomosis Device Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us

Contact Us:
Jatin Vimal
jvimal@delveinsight.com
+14699457679
Healthcare Consulting
https://www.delveinsight.com/consulting-services

About DelveInsight
DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

This release was published on openPR.